Investigating the candidacy of a lipoteichoic acid-based glycoconjugate as a vaccine to combat Clostridium difficile infection.

Andrew D Cox, Frank St Michael, Annie Aubry, Chantelle M Cairns, Philippa C R Strong, Alexander C Hayes, Susan M Logan
Author Information
  1. Andrew D Cox: Vaccine Program, Human Health Therapeutics Portfolio, National Research Council, Ottawa, ON, K1A 0R6, Canada, Andrew.Cox@nrc-cnrc.gc.ca.

Abstract

A lipoteichoic acid has recently been shown to be conserved in the majority of strains from Clostridium difficile and as such is being considered as a possible vaccine antigen. In this study we examine the candidacy of the conserved lipoteichoic acid by demonstrating that it is possible to elicit antibodies against C. difficile strains following immunisation of rabbits and mice with glycoconjugates elaborating the conserved lipoteichoic acid antigen. The present study describes a conjugation strategy that utilises an amino functionality, present at approximately 33 % substitution of the N-acetyl-glucosamine residues within the LTA polymer repeating unit, as the attachment point for conjugation. A maleimide-thiol linker strategy with the maleimide linker on the carboxyl residues of the carrier protein and the thiol linker on the carbohydrate was employed. Immunisation derived antisera from rabbits and mice, recognised all strains of C. difficile vegetative cells examined, despite an immune response to the linkers also being observed. These sera recognised live cells in an immunofluorescence assay and were also able to recognise the spore form of the bacterium. This study has illustrated that the LTA polymer is a highly conserved surface polymer of C. difficile that is easily accessible to the immune system and as such merits consideration as a vaccine antigen to combat C. difficile infection.

References

  1. Carbohydr Res. 2008 Mar 17;343(4):703-10 [PMID: 18237724]
  2. Glycoconj J. 2010 Oct;27(7-9):643-8 [PMID: 20922476]
  3. J Gen Microbiol. 1981 Jan;122(1):41-6 [PMID: 6798159]
  4. Chem Biol. 2011 May 27;18(5):580-8 [PMID: 21609839]
  5. Carbohydr Res. 2012 Jun 1;354:65-73 [PMID: 22560631]
  6. ACS Chem Biol. 2012 Aug 17;7(8):1420-8 [PMID: 22620974]
  7. Expert Rev Anti Infect Ther. 2010 May;8(5):555-64 [PMID: 20455684]
  8. Clin Infect Dis. 2008 Jan 15;46 Suppl 1:S43-9 [PMID: 18177221]
  9. Antimicrob Agents Chemother. 2012 Oct;56(10):5224-9 [PMID: 22850511]
  10. J Am Chem Soc. 2013 Jul 3;135(26):9713-22 [PMID: 23795894]
  11. Glycoconj J. 2011 Aug;28(6):397-410 [PMID: 21701793]
  12. Chem Commun (Camb). 2013 Aug 18;49(64):7159-61 [PMID: 23836132]
  13. J Clin Gastroenterol. 2011 Nov;45 Suppl:S159-67 [PMID: 21992957]
  14. Org Lett. 2011 Feb 4;13(3):378-81 [PMID: 21190352]
  15. Antimicrob Agents Chemother. 2012 Oct;56(10):5023-30 [PMID: 22802252]
  16. N Engl J Med. 2010 Jan 21;362(3):197-205 [PMID: 20089970]
  17. Am J Gastroenterol. 2012 Jan;107(1):89-95 [PMID: 22108454]
  18. J Gen Microbiol. 1982 Jun;128(6):1365-70 [PMID: 7119739]
  19. Vaccine. 2012 Jun 13;30(28):4249-58 [PMID: 22537987]
  20. J Biol Chem. 2011 Mar 18;286(11):8961-76 [PMID: 21216961]
  21. Hum Vaccin. 2011 Feb;7(2):170-82 [PMID: 21178398]
  22. J Med Microbiol. 2011 Aug;60(Pt 8):1070-1079 [PMID: 21415200]
  23. Expert Rev Vaccines. 2013 Apr;12(4):421-31 [PMID: 23560922]
  24. Proc Natl Acad Sci U S A. 1990 Jan;87(1):308-12 [PMID: 2104981]
  25. Glycoconj J. 2011 May;28(3-4):165-82 [PMID: 21590368]
  26. Carbohydr Res. 2002 Sep 9;337(16):1435-44 [PMID: 12204604]

MeSH Term

Animals
Antibodies, Bacterial
Bacterial Vaccines
Clostridioides difficile
Immunization
Lipopolysaccharides
Mice
Rabbits
Teichoic Acids
Vaccines, Conjugate

Chemicals

Antibodies, Bacterial
Bacterial Vaccines
Lipopolysaccharides
Teichoic Acids
Vaccines, Conjugate
lipoteichoic acid

Word Cloud

Created with Highcharts 10.0.0difficilelipoteichoicconservedCacidstrainsvaccineantigenstudypolymerlinkerClostridiumpossiblecandidacyrabbitsmicepresentconjugationstrategyresiduesLTArecognisedcellsimmunealsocombatinfectionrecentlyshownmajorityconsideredexaminedemonstratingelicitantibodiesfollowingimmunisationglycoconjugateselaboratingdescribesutilisesaminofunctionalityapproximately33%substitutionN-acetyl-glucosaminewithinrepeatingunitattachmentpointmaleimide-thiolmaleimidecarboxylcarrierproteinthiolcarbohydrateemployedImmunisationderivedantiseravegetativeexamineddespiteresponselinkersobservedseraliveimmunofluorescenceassayablerecognisesporeformbacteriumillustratedhighlysurfaceeasilyaccessiblesystemmeritsconsiderationInvestigatingacid-basedglycoconjugate

Similar Articles

Cited By